Legacy Capital Group California »

Cue Biopharma shares owned by Legacy Capital Group California

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Legacy Capital Group California from 13F filings

Historical chart of Legacy Capital Group California investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Legacy Capital Group California consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Legacy Capital Group California

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.6k 10k 0.76
2024-06-30 $12k 10k 1.24
2024-03-31 $19k 10k 1.89
2023-12-31 $26k 10k 2.64

More positions owned by Legacy Capital Group California

Apple (AAPL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Microsoft Corporation (MSFT)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Spdr Ser Tr Bloomberg Invt (FLRN)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Spdr Ser Tr Portfolio S&p500 (SPLG)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (FFEB)
Spdr Ser Tr Portfoli S&p1500 (SPTM)
NVIDIA Corporation (NVDA)
Pimco Etf Tr Multisector Bd (PYLD)
Fs Kkr Capital Corp (FSK)
Meta Platforms Cl A (META)
Spotify Technology S A SHS (SPOT)
Merck & Co (MRK)

View all positions for Legacy Capital Group California

Top funds holding Cue Biopharma

Bleichroeder
Slate Path Capital
Vanguard Group
BlackRock
BlackRock
Geode Capital Management
Robertson Stephens Wealth Management
Sigma Planning
Good Life Advisors
GSA Capital Partners
Goldman Sachs Group
Advisory Research
Bank of America Corporation
Stifel Financial
State Street Corporation

View all funds holding Cue Biopharma